Whoa! How Did I Miss This? PR from 4-27-2010 Plans are already underway to help position and market on an exclusive basis an exciting new product with enormous potential for the treatment of back and neck pain for which approximately $86 billion in treatment is spent annually on surgeries, nerve blocks, physical therapy and pain medications." -PR dated 4-27-2010.
Notice the word "exclusive"? In my opinion, they are dropping hints everywhere. If they have an FDA approved device at .0002 this company is a screaming bargain.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.